Top

Published in:

Open Access 01-12-2010 | Review

Proposed follow up programme after curative resection for lower third oesophageal cancer

Authors: LH Moyes, JE Anderson, MJ Forshaw

Published in: World Journal of Surgical Oncology | Issue 1/2010

Abstract

The incidence of oesophageal adenocarcinoma has risen throughout the Western world over the last three decades. The prognosis remains poor as many patients are elderly and present with advanced disease. Those patients who are suitable for resection remain at high risk of disease recurrence. It is important that cancer patients take part in a follow up protocol to detect disease recurrence, offer psychological support, manage nutritional disorders and facilitate audit of surgical outcomes. Despite the recognition that regular postoperative follow up plays a key role in ongoing care of cancer patients, there is little consensus on the nature of the process. This paper reviews the published literature to determine the optimal timing and type of patient follow up for those after curative oesophageal resection.

Crew KD, Neuqut AI: Epidemiology of upper gastrointestinal malignancies. Seminars in Oncology. 2004, 31: 450-464. 10.1053/j.seminoncol.2004.04.021.CrossRefPubMed

Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG: Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg. 2004, 91: 943-947. 10.1002/bjs.4596.CrossRefPubMed

Lerut T, Moons J, Coosemans W, Decaluwé H, Decker G, De Leyn P, Nafteux P, Van Raemdonck D: Multidisciplinary treatment of advanced cancer of the oesophagus and gastroesophageal junction: a European centre's approach. Surg Oncol Clin N Am. 2008, 17: 485-502. 10.1016/j.soc.2008.02.007.CrossRefPubMed

Forshaw MJ, Gossage JA, Stephens J, Strauss D, Botha AJ, Atkinson S, Mason RC: Centralisation of oesophagogastric cancer services: can specialist units deliver?. Ann R Coll Surg Engl. 2006, 88 (6): 566-70. 10.1308/003588406X130624.PubMedCentralCrossRefPubMed

The National Oesophagogastric Cancer Audit: An audit of the care received by people with oesophagogastric cancer in England and Wales - Second Annual Report. 2009

Mariette C, Balon J, Piessen G, Fabre S, Van Seuningen I, Triboulet JP: Pattern of recurrence following complete resection of oesophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003, 97: 1616-1623. 10.1002/cncr.11228.CrossRefPubMed

de Manzoni G, Pedrazzani C, Pasini : Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction. EJSO. 2003, 29: 506-510. 10.1016/S0748-7983(03)00098-2.CrossRefPubMed

Fumagalli U, Panel of Experts: Resective surgery for cancer of the thoracic oesophagus -results of a consensus conference held at the VIth World Congress of the International Society for Diseases of the Oesophagus. Dis Esophagus. 2005, 9: 30-38.

Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, Ancona E: Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Archives of Surgery. 2009, 144: 247-254. 10.1001/archsurg.2008.574.CrossRefPubMed

10.

Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR: The number of lymph nodes removed predicts survival in oesophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008, 248: 549-556. 10.1097/SLA.0b013e3181904f3c.CrossRefPubMed

11.

Mariette C, Taillier G, Van Seuingen I, Triboulet JP: Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thor Surg. 2004, 78: 1177-1183. 10.1016/j.athoracsur.2004.02.068.CrossRef

12.

Allum WH, Griffin SM, Watson S, Colin-Jones D: Guidelines for the management of oesophageal and gastric cancer. Gut. 2002, 50: 1-23. 10.1136/gut.50.1.1.CrossRef

13.

SIGN - Management of oesophageal and gastric cancer. 2006,http://www.sign.ac.uk

14.

Stahl M, Oliveira J: Esophageal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology. 2009, 20 (S4): 32-33.PubMed

15.

NCCN Practice Guidelines in Oncology - Oesophageal cancer. 2009, http://www.nccn.org

16.

Leers JM, DeMeester SR, Chan N, Ayazi S, Oezcelik A, Abate E, Banki F, Lipham JC, Hagen JA, DeMeester TR: Clinical characteristics, biologic behaviour and survival after oesophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal oesophagus. J Thorac Cardiovasc Surg. 2009, 138: 594-602. 10.1016/j.jtcvs.2009.05.039.CrossRefPubMed

17.

Kiebert GM, Welvaart K, Kievit J: Psychological effects of routine follow-up on cancer patients after surgery. Eur J Surg. 1993, 159: 601-607.PubMed

18.

McCorry NK, Dempster M, Clarke C, Doyle R: Adjusting to life after oesophagectomy: the experience of survivors and carers. Qualitative Health Research. 2009, 19: 1485-1494. 10.1177/1049732309348366.CrossRefPubMed

19.

Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, Brada M, O'Brien M, Smith I: Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ. 2002, 325: 1145-10.1136/bmj.325.7373.1145.PubMedCentralCrossRefPubMed

20.

James ND, Guerrero D, Brada M: Who should follow up cancer patients? Nurse specialist based outpatient care and the introduction of a phone clinic system. Clinical Oncology. 1994, 6: 283-287. 10.1016/S0936-6555(05)80267-5.CrossRefPubMed

21.

Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE: American Society of Clinical Oncology. American Society of Clinical Oncology 2006 Update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006, 24: 1-7. 10.1200/JCO.2005.03.7234.CrossRef

22.

Renehen AG, Egger M, Saunders MP, O'Dwyer ST: Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-anlysis for randomised trials. BMJ. 2002, 324: 813-10.1136/bmj.324.7341.813.CrossRef

23.

Jeffrey M, Hickey BE, Hinder PN: Follow up strategies for patients for non-metastatic colorectal cancer. Cochrane Database of Systematic Reviews. 2007, CD002200-

24.

Siewert JR, Feith M, Werner M, Stein HJ: Adenocarcinoma of the oesophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg. 2000, 232: 353-361. 10.1097/00000658-200009000-00007.CrossRef

25.

Orringer MB, Marshall B, Iannettoni MD: Transhiatal oesophagectomy: clinical experience and refinements. Ann Surg. 1999, 230: 392-400. 10.1097/00000658-199909000-00012.PubMedCentralCrossRefPubMed

26.

Hulscher JB, van Sandick JW, Tijssen JB, Obertop H, van Lanschot JJ: The recurrence pattern of oesophageal carcinoma after transhiatal resection. J Am Coll Surg. 2000, 191: 143-148. 10.1016/S1072-7515(00)00349-5.CrossRefPubMed

27.

Gall CA, Rieger NA, Watchow DA: Positive proximal resection margins after resection for carcinoma of the oesophagus and stomach: effect on survival and symptom recurrence. Aust N Z J Surg. 1996, 66: 734-737. 10.1111/j.1445-2197.1996.tb00732.x.CrossRefPubMed

28.

Saad RS, Lindner JL, Liu Y, Silverman JF: Lymphatic vessel density as prognostic marker in oesophageal adenocarcinoma. Am J Clin Pathol. 2009, 131: 92-98. 10.1309/AJCPKWUQSIPVG90H.CrossRefPubMed

29.

Cen P, Hofstetter WL, Correa AM: Lymphovascular invasion as a tool to further subclassify T1b oesophageal adenocarcinoma. Cancer. 2008, 112: 1020-1027. 10.1002/cncr.23265.CrossRefPubMed

30.

Hagan JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR: Curative resection for oesophageal adenocarcinoma; analysis of 100 en bloc oeosphagectomies. Annals of Surgery. 2001, 234: 520-531. 10.1097/00000658-200110000-00011.CrossRef

31.

Lagarde SM, Reitsma JB, Ten Kate FJ, Busch OR, Obertop H, Zwinderman AH, Moons J, van Lanschot JJ, Lerut T: Predicting individual survival after potentially curative oesophagectomy for adenocarcinoma of the oesophagus or gastroesophageal junction. Annals of Surgery. 2008, 248: 1006-1013. 10.1097/SLA.0b013e318190a0a2.CrossRefPubMed

32.

Lerut T, Moons J, Coosemans W, Van Raemdonck D, De Leyn P, Decaluwé H, Decker G, Nafteux P: Postoperative complications after transthoracic oesophagectomy for cancer of the oesophagus and gastroesophageal junction are correlated with early cancer recurrence. Annals of Surgery. 2009, 250: 798-807. 10.1097/SLA.0b013e3181bdd5a8.CrossRefPubMed

33.

Banki F, Yacoub WN, Hagen JA, Mason RJ, Ayazi S, DeMeester SR, Lipham JC, Danenberg K, Danenberg P, DeMeester TR: Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer. J Am Coll Surg. 2008, 207: 30-35. 10.1016/j.jamcollsurg.2008.01.004.CrossRefPubMed

34.

Rankin SC: Oesophageal cancer: assessment of response and follow up. Cancer Imaging. 2007, 7: S67-69. 10.1102/1470-7330.2007.9019.PubMedCentralCrossRefPubMed

35.

Lightdale CJ, Kulkami KG: Role of endoscopic ultrasonography in staging and follow up of oesophageal cancer. J Clin Oncol. 2005, 23: 4483-4489. 10.1200/JCO.2005.20.644.CrossRefPubMed

36.

Roedl JB, Harisinghani MG, Colen RR, Fischman AJ, Blake MA, Mathisen DJ, Mueller PR: Assessment of treatment response and recurrence in oesophageal carcinoma based on tumour length and standardised uptake value on positron emission tomography-computed tomography. Annals of Thoracic Surgery. 2008, 86: 1131-1138. 10.1016/j.athoracsur.2008.05.019.CrossRefPubMed

37.

Bruzzi JF, Munden RF, Truong MT, Marom EM, Sabloff BS, Gladish GW, Iyer RB, Pan TS, Macapinlac HA, Erasmus JJ: PET/CT of esophageal cancer: its role in clinical management. RadioGraphics. 2007, 29: 1635-1652. 10.1148/rg.276065742.CrossRef

38.

Papagrigoriasdis S: Follow-up of patients with colorectal cancer: The evidence is in favour but we are still in need of a protocol. Int J Surg. 2007, 5: 120-128. 10.1016/j.ijsu.2006.04.004.CrossRef

39.

Papgrigoriadis S, Heyman B: Patients' views on follow up of colorectal cancer: implications for risk communications and decision-making. Postgrad Med. 2003, 73: 403-407.CrossRef

40.

Stiggelbout AM, de Haes JC, Keibert GM, Kievit J, Leer JWH: Trade offs between quality and quantity of life: development of the QQ questionnaire for cancer patient attitudes. Med Decis Making. 1996, 16: 184-192. 10.1177/0272989X9601600211.CrossRefPubMed

41.

Rojas MP, Telaro E, Russo A, Moschetti I, Coe L, Fossati R, Palli D, del Roselli TM, Liberati A: Follow-up strategies for women treated for early breast cancer. Cochrane Library. 2005, CD001768-

42.

Chang AC, Ji H, Birkmeyer NJ, Orrinder MB, Birkmeyer JD: Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008, 85: 424-429. 10.1016/j.athoracsur.2007.10.007.CrossRefPubMed

43.

Hulscher JB, van Sandrick JW, de Boer AG, Winhoven BP, Tissen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. NEJM. 2002, 347: 1662-1669. 10.1056/NEJMoa022343.CrossRefPubMed

44.

Morgan MA, Lewis WG, Hopper AN, Escofet X, Havard TJ, Brewster AE, Crosby TD, Roberts SA, Clark GW: Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer. Dis Esophagus. 2007, 20: 225-231. 10.1111/j.1442-2050.2007.00676.x.CrossRefPubMed

45.

Gockel I, Heckhoff S, Messow CM, Kneist W, Junginger T: Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the longterm prognosis?. World J Surg Oncol. 2005, 3: 40-10.1186/1477-7819-3-40.PubMedCentralCrossRefPubMed

46.

Rizzeto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR: En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2008, 135: 1228-1236. 10.1016/j.jtcvs.2007.10.082.CrossRef

47.

Omloo JM, Lagarde DM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, Ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomised clinical trial. Ann Surg. 2007, 246: 992-1001. 10.1097/SLA.0b013e31815c4037.CrossRefPubMed

48.

Schipper PH, Cassivi SD, Deschamps C, Rice DC, Nichols FC, Allen MS, Pairolero PC: Locally recurrent esophageal carcinoma: when is re-resection indicated?. Ann Thor Surg. 2005, 80: 1001-1006. 10.1016/j.athoracsur.2005.03.099.CrossRef

49.

Sreedharan A, Harris K, Crellin A, Forman D, Everett SM: Interventions for dysphagis in oesophageal cancer. Cochrane Database of Systematic Reviews. 2009, 4: CD005048-PubMed

50.

Wong RKS, Maltaner R: Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localised carcinoma of the esophagus. Cochrane Database of Systematic Reviews. 2006, 1: CD002092-PubMed

51.

Sutcliffe RP, Forshaw MJ, Tandon R, Rohatgi A, Strauss DC, Botha AJ, Mason RC: Anastomotic strictures and delayed gastric emptying after oesophagectomy; incidence, risk factors and management. Dis Esophagus. 2008, 21: 712-717. 10.1111/j.1442-2050.2008.00865.x.CrossRefPubMed

52.

Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC: Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. BJS. 2009, 96: 724-733. 10.1002/bjs.6584.CrossRef

53.

Lagarde SM, Reitsma JB, de Castro SM, Ten Kate FJ, Busch OR, van Lanschot JJ: Prognostic normogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. Br J Surg. 2007, 94: 1361-1368. 10.1002/bjs.5832.CrossRefPubMed

54.

Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC: An elevated C-reactive protein concentration, prior to surgery predicts poor cancer-specific survival in patients undergoing resection from gastroesophageal cancer. Br J Cancer. 2006, 94: 1568-1571.PubMedCentralPubMed

55.

Ikeda M, Natsugoe S, Ueno S, Baba M, Aikou T: Significant host and tumour related factors for predicting prognosis in patients with oesophageal carcinoma. Ann Surg. 2003, 238: 197-202.PubMedCentralPubMed

56.

Deans DAC, Wigmore SJ, de Beaux AC, Paterson-Brown S, Garden OJ, Fearon KC: Clinical prognostic scoring system to aid decision making in gastro-oesophageal cancer. Br J Surg. 2007, 94: 1501-1508. 10.1002/bjs.5849.CrossRefPubMed

57.

Sato F, Shimada Y, Selary FM, Shibata D, Maeda M, Watanabe G, Mori Y, Stass SA, Imamura M, Meltzer SJ: Prediction of survival in patients with esophageal carcinoma using artificial neural networks. Cancer. 2005, 103: 1596-1605. 10.1002/cncr.20938.CrossRefPubMed

Title: Proposed follow up programme after curative resection for lower third oesophageal cancer
Authors: LH Moyes
JE Anderson
MJ Forshaw
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2010
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/1477-7819-8-75

At a glance: The STEP trials

Springer Medicine

Proposed follow up programme after curative resection for lower third oesophageal cancer

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Mixed germ cell tumor metastatic to the skin: Case report and literature review

Probing the link between oestrogen receptors and oesophageal cancer

CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion

Late local recurrence of dermatofibrosarcoma protuberans in the skin of female breast

Major surgery in an osteosarcoma patient refusing blood transfusion: case report

Retroperitoneal lymph node dissection for residual masses after chemotherapyin nonseminomatous germ cell testicular tumor